glp-1 receptor Understanding agonists and their impact on drug discovery Regulation of GLP-1 and Glucagon
Description
Objective To assess whether GLP-1 RA therapy is associated with improved clinical outcomes in patients with IIH compared with conventional therapies
25 Liraglutide was evaluated in 24 subjects with mild, moderate, severe, or no hepatic impairment
PSM with age, sex, race, and disease comorbidities was then conducted, yielding 162,253 matched patients for analysis
Intervention: Treatment with GLP-1-RA
[DOI] [PubMed] [Google Scholar] 168.Fras J.P., Davies M.J., Rosenstock J., Prez Manghi F.C., Fernndez Land L., Bergman B.K., Liu B., Cui X., Brown K
doi: 10.4254/wjh.v7.i10.1297
